- 1 Renal Handling of Potassium
- 2 Reabsorption
- 3 Secretion
- 4 Factors Affecting Secretion
- 5 Clinical Relevance – Hyperkalaemia
- 6 Hypokalaemia
External balance of potassium is achieved through balancing dietary potassium intake, intracellular and extracellular potassium levels and excretion by kidneys.
Extracellular potassium concentration is usually maintained within 3.5-5 mmol/L. This narrow window of control is critically important as the difference between the intracellular and extracellular potassium affects electrically excitable muscle and nerve cells due to its effect on the resting membrane potential. Intracellular potassium levels, which are maintained within 120-150mmol/L, are important for enzyme function, cell division and growth. It also contributes to acid-base and cell volume regulation. This article focuses on the external balance of potassium within the body.
Renal Handling of Potassium
Potassium levels are controlled by regulating its secretion and reabsorption. This is done by the kidneys to match potassium intake and maintain an external balance of potassium
Potassium is freely filtered at the glomerulus and passes through to the proximal convoluted tubule (PCT) and loop of Henle, where most of it is reabsorbed. There is some reabsorption in the distal convoluted tubule and collecting duct, but potassium secretion also occurs at these sites.
The freely filtered potassium is then passed through the kidney tubules. Two-thirds of the filtered K+ is reabsorbed in the PCT and approximately 20% is reabsorbed in the thick ascending limb of the Loop of Henle. This means a very small proportion of K+ reaches the distal nephron.
Proximal Convoluted Tubule
K+ reabsorption occurs passively within the PCT and about two-thirds is reabsorbed here. It occurs via a paracellular mechanism and is directly proportional to water and Na+ movement.
The Na+-K+-ATPase causes Na+ to move out of the proximal tubule cell and drives K+ into the cell. The extrusion of Na+ creates an osmotic gradient and an electrochemical gradient. Water moves out of the PCT down the osmotic gradient and Cl– moves down the electrochemical gradient. K+ is reabsorbed and follows Cl– into the bloodstream.
Thick Ascending Limb of Loop of Henle
In this section of the nephron roughly 20% of K+ is reabsorbed through transcellular and paracellular pathways.
Na+-K+-ATPase on the basolateral membrane pumps Na+ out into the bloodstream and pumps K+ into the thick ascending limb which keeps the sodium concentration in the cell low. This creates a gradient for the sodium-potassium-chloride (NKCC2) cotransporter on the apical membrane. NKCC2 pumps Na+, K+ and 2 Cl– into the cell from the lumen. Intracellular K+ can enter the bloodstream through K+-Cl– symporter or through the K+ uniporter.
Movement of K+ through apical renal outer medullary K+ (ROMK) channels. This leads to a positive voltage in the lumen which provides a driving force for passive reabsorption of K+.
Distal convoluted tubule and cortical collecting duct
Around 10% of filtered potassium is reabsorbed here when the body is attempting to preserve potassium. It occurs via the transcellular pathway and is mediated by alpha and beta intercalated cells. Structurally, the initial collecting tubule and cortical collecting duct are both composed of 70% principal cells (secretion of K+) and 30% intercalated cells (reabsorption of K+).
In this section, we are considering the intercalated cells in the reabsorption of K+.
There are two steps in the reabsorption of potassium here:
- The apical H+-K+-ATPase mediates the movement of H+ into the lumen, driving K+into the intercalated cell.
2. Then, the basolateral K+ channel allows the K+ inside the intercalated cell to leak out into the bloodstream.
In potassium depletion, the number of H+-K+-ATPase pumps increase significantly in order to reabsorb as much K+ as possible. However, reabsorbing K+ drives H+ secretion into the lumen. This leads to hypokalaemic alkalosis.
Potassium secretion occurs mainly in the late distal collecting tubule (DCT) and the collecting duct (CD). The purpose of secretion is to control the serum potassium levels in the long term. The rate of secretion is variable and can be increased or decreased due to several factors which will be considered later in the article.
With a normal or high K+ diet, the substantial secretion varies between 15-20%. However, with a low K+ diet or depletion, there is very little secretion.
Distal Convoluted Tubule and Collecting duct
Potassium secretion in the late DCT and CD mediated via principal cells and the rate can be varied depending on need.
The principal cells of the late DCT and collecting duct contain ENaC on the apical membrane and Na+-K+-ATPase on the basolateral membrane. The activity of Na+-K+-ATPase results in Na+ moving out into the blood from the principal cell and in turn drives K+ into the principal cell from the bloodstream. This leads to a decrease in intracellular Na+ concentration and an accumulation of intracellular K+.
The high intracellular K+ in comparison to the luminal K+ concentration creates a chemical gradient which is ideal for potassium secretion from the principal cell into the lumen.
Due to the action of Na+-K+-ATPase, the low intracellular [Na+] allows for a concentration gradient between the lumen and principal cell. Na+ moves from the lumen into the cell down the concentration gradient through ENaC.
This creates a favourable electrochemical gradient which allows for K+ secretion via K+ channels on the apical membrane.
Factors Affecting Secretion
- High ECF [K+] – This stimulates the Na+-K+-ATPases, leading to increased permeability of K+ channels on the apical membrane. This results in increased secretion of K+ into the lumen.
- Aldosterone – This stimulates the Na+-K+-ATPases in the basolateral membrane. This stimulates K+ channels and ENaCs in the apical membrane, leading to increased K+ secretion.
Acidosis – This leads to increased H+ secretion into lumen to correct acidosis
- Due to H+-K+-ATPase, when H+ is secreted into lumen, K+ is driven back into the cell, leading to decreased K+ secretion.
Alkalosis – The kidneys try to decrease secretion of H+, increasing secretion of K+ in turn
- Stimulates Na+-K+-ATPase, leading to increased K+ channel permeability.
High luminal flow – The increased flow rate washes away luminal K+, meaning there is a constant concentration gradient available. This leads to increased K+ secretion.
- This increased luminal flow also increases Na+ delivery to the tubule cells which stimulates Na+ uptake through ENaC. This leaves the lumen in a negative potential, encouraging K+ to be secreted through the apical K+ channel.
Clinical Relevance – Hyperkalaemia
Hyperkalaemia is defined as extracellular [K+] > 5mmol/L. It can caused by decreased excretion, redistribution from intracellular to extracellular or increased K+ intake. Decreased excretion can be a result of renal failure, which decreases the or Addison’s disease, which would lead to increased K+ reuptake. Redistribution is mainly caused by metabolic acidosis (e.g. diabetic ketoacidosis). This is because H+ is reabsorbed into the cells to try and decrease the pH, so K+ is excreted to maintain electrical potential. Increased K+ intake is usually due to high intake of salt substitutes or transfusion of stored blood.
Clinical features of hyperkalaemia
Kussmaul respiration (rapid, deep breaths)– usually due to an underlying metabolic acidosis trying to be compensated by removing CO2 faster
Muscle weakness – the changes in membrane potential affect the muscle ability to contract, causing weakness.
Cardiac function is also affected due to the chemical gradient of K+ being decreased. This in turn, makes the cardiac cells less likely to depolarize. ECG changes associated with this include:
- Tented (or peaked) T waves
- Flattened/absent P waves
- Increased PR segment length
- Abnormal QRS complexes
Hyperkalaemia can be a medical emergency and can be quite difficult to treat. This is because most symptoms of hyperkalaemia are only visible once [K+] reaches a level high enough to cause cardiac arrest.
Hyperkalaemia should be treated even before a definitive cause of the hyperkalaemia is found. Calcium gluconate can be given as an i.v. bolus. This protects the heart by raising the threshold potential, making it easier to depolarize. Nebulised B2 agonists e.g. salbutamol or oral/i.v. insulin-glucose combinations can also be given to encourage K+ reuptake into cells.
Hypokalaemia is when there is not enough K+ in the ECF outside cells and in the blood. To learn more about it, click here.